DSG & Pharmaceutical Company Engage in Global Effort in Early Detection of Major Diseases

DSG, a leader in electronic data capture (EDC) has teamed up with a leading-edge pharmaceutical technology company to speed the early detection of Alzheimer’s, Parkinson’s, and Diabetes.

The focus is on developing molecular imaging products that are leading the way to the early detection of human diseases. DSG’s eCaseLink™ EDC (Electronic Data Capture) supports three current clinical trials for Alzheimer’s disease, Parkinson’s disease and Diabetes. eCaseLink™ supplies real-time capability to review case documents and metrics across all study sites, significantly increasing clinical trial management speed, while reducing study management costs by as much as 30 percent.

DSG’s eCaseLink™ allows the pharmaceutical diagnostic and therapeutic company not only to collect and manage their data in real time, but it also gives them the option to add needed functionality as studies progress. They have found that the innovation of the eCaseLink™ product suite, combined with the experience and dedication of the DSG team, is paying immediate and continued dividends for their clinical trial management process.

“We are delighted to provide this Pharma leader with the latest critical technology solutions, helping to reach an incredibly important goal – the early detection of debilitating diseases,” said Tony Varano, CEO, DSG, Inc. “What is especially gratifying is that DSG provides select solution modules specific to their needs, rather than the ‘cookie cutter’ approach to most clinical trial data collection solutions.”

About DSG

DSG Inc. supports clinical trial data collection and management with innovative technology solutions including Electronic Data Capture with specialized Clinical Data Management services, Electronic Patient Diaries, Clinical Trial Management Systems and digital on-demand Case Report Form publishing management software. DSG’s products allow user-friendly, accurate and efficient data capture at any investigator site regardless of the technological infrastructure. DSG has successfully supported over 800 clinical trials for more than 325 companies at over 18,000 sites in over 68 countries. Founded in 1992, DSG is a global company headquartered in Malvern, Pa., with additional offices in the U.S., Japan and India. For more information, please visit www.dsg-us.com.

All products and services mentioned in this announcement are the property of their respective owners.